Unknown

Dataset Information

Use of a comprehensive frailty assessment to predict morbidity in patients with multiple myeloma undergoing transplant.


ABSTRACT: Multiple myeloma (MM) is a disease of aging adults and autologous stem cell transplant (ASCT) is considered the standard of care. As the population ages a growing number of older adults will undergo ASCT and an objective approach to estimate physiologic reserve and transplant morbidity risk is warranted. Here, we evaluate assess p16INK4a (p16), a molecular aging biomarker, along with geriatric metrics to determine risk of transplant toxicity.

Methods

We prospectively evaluated 100 MM patients for frailty before and after ASCT using a Geriatric Assessment (GA) and collected T-cells for analysis of p16 using a custom nanostring codeset.

Results

Pre-transplant physical function was predicative of hospital length of stay (LOS). Each one-unit increase in physical functi

SUBMITTER: Rosko AE 

PROVIDER: S-EPMC6320732 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature